Outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) according to the presence of the EGFR T790M mutation and BRCA1 mRNA expression levels in pretreatment biopsies

被引：5
|
作者：
Rosell, R.
Molina, M. A.
Costa, C.
Taron, M.
Bertran-Alamillo, J.
Mayo, C.
Benlloch, S.
Moran, T.
Cardenal, F.
Porta, R.
机构：
[1] Catalan Inst Oncol, Badalona, Spain
[2] USP Inst Univ Dexeus, Pangaea Biotech, Barcelona, Spain
[3] USP Dexeus Univ Inst, Pangaea Biotech, Barcelona, Spain
[4] USP Inst Dexeus, Pangaea Biotech, Barcelona, Spain
[5] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona, Spain
[6] Bellvitge Hosp, Catalan Inst Oncol, Barcelona, Spain
[7] Hosp Josep Trueta, Catalan Inst Oncol, Girona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7514
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Different characteristics and survival in non-small cell lung cancer patients with primary and acquired EGFR T790M mutation
    Wang, Shuyuan
    Yan, Bo
    Zhang, Yanwei
    Xu, Jianlin
    Qiao, Rong
    Dong, Yu
    Zhang, Bo
    Zhao, Yiming
    Zhang, Lele
    Qian, Jie
    Lu, Jun
    Zhao, Ruiying
    Han, Baohui
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (11) : 2880 - 2886
  • [22] Clinical Utility of Plasma EGFR T790M Mutation Detection in Advanced Non-Small Cell Lung Cancer Patients According to RECIST Criteria
    Barrera, L.
    Borbolla-Escoboza, J. R.
    Montes-Servin, E.
    Macedo-Perez, E. O.
    Barron, F.
    Molina Romero, C.
    Hernandez Martinez, J.
    Arrieta, O.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1850 - S1850
  • [23] Clinical utility of repeated rebiopsy for EGFR T790M mutation detection in non-small cell lung cancer
    Lee, Eun Hye
    Kwak, Se Hyun
    Kim, Kyeong Yeon
    Kim, Chi Young
    Lee, Sang Hoon
    Heo, Seok-Jae
    Chang, Yoon Soo
    Kim, Eun Young
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [24] Managing EGFR T790M Mutation in Advanced Non-Small Cell Lung Cancers in THAILAND
    Prempree, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2136 - S2136
  • [25] An evaluation of aumolertinib for the treatment of EGFR T790M mutation-positive non-small cell lung cancer
    Wang, Jingyi
    Wu, Lin
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (06) : 647 - 652
  • [26] Osimertinib for the Treatment of Metastatic EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
    Khozin, Sean
    Weinstock, Chana
    Blumenthal, Gideon M.
    Cheng, Joyce
    He, Kun
    Zhuang, Luning
    Zhao, Hong
    Charlab, Rosane
    Fan, Ingrid
    Keegan, Patricia
    Pazdur, Richard
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2131 - 2135
  • [27] Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
    Skoulidis, Ferdinandos
    Papadimitrakopoulou, Vassiliki A.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (03) : 618 - 622
  • [28] Efficacy of PD-1 inhibitors in patients with metastatic non-small cell lung cancer (NSCLC) with KRAS or EGFR T790M mutations
    Sharma, Nitika
    Stroud, Chipman Robert Geoffrey
    Walker, Paul R.
    Cherukuri, Sulochana Devi
    Muzaffar, Mahvish
    Cherry, Cynthia R.
    Parent, Teresa
    Hardin, Jessica
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR
    Hwang, Ki-Eun
    Kwon, Su-Jin
    Kim, Young-Suk
    Park, Do-Sim
    Kim, Byoung-Ryun
    Yoon, Kwon-Ha
    Jeong, Eun-Taik
    Kim, Hak-Ryul
    [J]. EXPERIMENTAL CELL RESEARCH, 2014, 323 (02) : 288 - 296
  • [30] Analysis of Acquired EGFR T790M Mutation in Patients with Non-Small Cell Lung Cancer Who Received Icotinib Progress
    Huang, R.
    Xu, C.
    Wang, W.
    Li, J.
    He, C.
    Zhu, Y.
    Zhuang, W.
    Huang, Z.
    Chen, Y.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S882 - S882
12345